Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors
US-12285431-B2 · Apr 29, 2025 · US
G1 Therapeutics Inc holds 134 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 134 |
| Recent patents | 14 |
| First publication | Jan 15, 2015 |
| Latest publication | Apr 29, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12285431-B2 · Apr 29, 2025 · US
US-12168666-B2 · Dec 17, 2024 · US
US-12139494-B2 · Nov 12, 2024 · US
US-2024199556-A1 · Jun 20, 2024 · US
US-2024150369-A1 · May 9, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12285431-B2 · Apr 29, 2025 · US
US-12168666-B2 · Dec 17, 2024 · US
US-12139494-B2 · Nov 12, 2024 · US
US-2024199556-A1 · Jun 20, 2024 · US
US-2024150369-A1 · May 9, 2024 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K31/519 | 90 |
| C07D487/14 | 84 |
| A61P35/00 | 81 |
| A61K31/527 | 70 |
| A61K45/06 | 66 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 131 |
| Chemistry & Metallurgy | 110 |
| Cross-Sectional Technologies | 3 |
| Physics | 1 |
Answers are generated from the same data shown on this page.